Effects of alcohol septal ablation on coronary microvascular function and myocardial energetics in hypertrophic

Stefan A J Timmer1, Paul Knaapen, Tjeerd Germans

  • 1Dept. of Cardiology, 5F, VU Univ. Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.

Insights

Alcohol septal ablation (ASA) improves coronary microvascular function and myocardial energetics in hypertrophic cardiomyopathy (HCM) patients by reducing left ventricular outflow tract obstruction. This procedure enhances coronary vasodilator reserve and myocardial efficiency, indicating reversibility of microvascular dysfunction.

Area of Science:

  • Cardiology
  • Cardiovascular Imaging
  • Interventional Cardiology

Background:

  • Obstructive hypertrophic cardiomyopathy (HCM) is associated with left ventricular outflow tract (LVOT) obstruction and impaired coronary microcirculation.
  • Alcohol septal ablation (ASA) is a treatment for symptomatic HCM, but its effects on myocardial energetics and microvascular function require further investigation.

Purpose of the Study:

  • To investigate the impact of ASA on microcirculatory function and myocardial energetics in patients with obstructive HCM.
  • To assess changes in left ventricular outflow tract gradient (LVOTG), myocardial blood flow (MBF), coronary vasodilator reserve (CVR), and myocardial external efficiency (MEE) after ASA.

Main Methods:

  • A prospective study involving 15 patients with obstructive HCM undergoing ASA.
  • Echocardiography for LVOT gradient assessment.
  • [(15)O]water PET for MBF and CVR.
  • Cardiovascular magnetic resonance imaging for LV mass and volumes.
  • [(11)C]acetate PET for MVo(2) and MEE in a subset of patients.

Main Results:

  • ASA significantly reduced peak LVOTG and LV mass.
  • Coronary vasodilator reserve (CVR) increased post-ASA, particularly in the subendocardium, correlating with reduced LVOTG.
  • Myocardial external efficiency (MEE) improved significantly after ASA.

Conclusions:

  • Coronary microvascular dysfunction in obstructive HCM is at least partially reversible after relief of LVOT obstruction via ASA.
  • ASA favorably impacts myocardial energetics and improves subendocardial microvascular function.
  • The reduction in LVOT obstruction significantly influences microvascular function, highlighting the role of loading conditions.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...